Medtronic names Kweli Thompson to lead Neuroscience unit as Brett Wall departs
Medtronic said Brett Wall is leaving his role as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson will take over the role effective June 1, 2026. Mr. Wall will stay on as an employee until September 1, 2026 to help with the transition and will receive severance under the company's executive practices. The change is a leadership transition for one of Medtronic's business portfolios, and the filing contains no financial results or guidance.
Key points
- Brett Wall departs as Executive Vice President and President, Neuroscience Portfolio
- Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, takes over the Neuroscience role effective June 1, 2026
- Mr. Wall remains an employee until September 1, 2026 to assist with the transition
- Severance follows practices described in the 2025 Proxy Statement filed August 25, 2025
The filing
Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 18, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.